Allelic loss on chromosomes 3p, 5q and 17p in renal cell carcinomas

Pathology International

Volumn 47, Issue 2-3, 1997, Pages 79-83

  Sugimura, Jun ^a   Tamura, Gen ^a   Suzuki, Yasushi ^a   Fujioka, Tomoaki ^a  

^a IWATE MEDICAL UNIVERSITY   (Japan)

Author keywords

interferon regulatory factor 1; loss of heterozygosity; renal cell carcinoma; tumor suppressor gene

Indexed keywords

ARTICLE; CARCINOGENESIS; CHROMOSOME 17P; CHROMOSOME 3P; CHROMOSOME 5Q; CHROMOSOME DELETION; CHROMOSOME LOSS; CHROMOSOME MAP; CONTROLLED STUDY; GENE LOCUS; HETEROZYGOSITY LOSS; HUMAN; HUMAN TISSUE; KIDNEY CARCINOMA; PRIORITY JOURNAL;

EID: 0030907705     PISSN: 13205463     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1440-1827.1997.tb03724.x     Document Type: Article

References (27)

1. Kashiwaba M, Tamura G, Ishida M. Aberrations of the APC gene in primary breast carcinoma. J. Cancer Res. Clin. Oncol. 1994; 120: 727-731.
2. Ogasawara S, Maesawa C, Tamura G, Satodate R. Frequent microsatellite alterations on chromosome 3p in esophageal squamous cell carcinoma. Cancer Res. 1995; 55: 891-894.
3. Tamura G, Sakata K, Maesawa C et al. Microsatellite alterations in adenoma and differentiated adenocarcinoma of the stomach. Cancer Res. 1995; 55: 1933-1936.
4. Suzuki Y, Tamura G, Maesawa C, Fujioka T, Kubo T, Satodate R. Analysis of genetic alterations in renal cell carcinoma using the polymerase chain reaction. Virchows Archiv. 1994; 424: 453-457.
5. Suzuki Y, Tamura G, Satodate R, Fujioka T. Infrequent mutation of p53 gene in human renal cell carcinoma detected by polymerase chain reaction single-strand conformation polymorphism analysis. Jpn. J. Cancer Res. 1992; 83: 233-235.
6. Morita R, Ishikawa J, Tsutsumi M et al. Allelotype of renal cell carcinoma. Cancer Res. 1991; 51: 820-823.
7. Morita R, Saito S, Ishikawa J et al. Common regions of deletion on chromosomes 5q, 6q and 10q in renal cell carcinoma. Cancer Res. 1991; 51: 5817-5820.
8. Hermanek P, Sobin LH, eds. TNM Classification of Malignant Tumours, 4th edn. Springer-Verlag, Berlin, 1987.
9. Mostofi FK, ed. Histological typing of kidney tumors. World Health Organization, Geneva, 1981.
10. Sambrook J, Fritsch EF, Maniatis T. Molecular Cloning: A Laboratory Manual, 2nd edn. Cold Spring Harbor Laboratory, New York, 1989.
11. Li H, Schmidt L, Duh F-MC et al. Three polymorphic dinucleotide repeats near the von Hippel Lindau (VHL) disease gene on human chromosome 3: D3S587; D3S1317; D3S1435. Hum. Mol. Genet. 1993; 2: 1326.
12. Sugimura T. Multistep carcinogenesis: A 1992 perspective. Science 1992; 258: 603-607.
13. Uchida T, Wada C, Wang C, Egawa S, Ohtani H, Koshiba K. Genomic instability of microsatellite repeats and mutations of H-, K-, and N-ras, and p53 genes in renal cell carcinoma. Cancer Res. 1994; 54: 3682-3685.
14. Brauch H, Pomer S, Hieronymus T, Schadt T, Löhrke H, Komitowski D. Genetic alterations in sporadic renal-cell carcinoma: Molecular analyses of tumor suppressor gene harboring chromosomal regions 3p, 5q and 17p. World J. Urol. 1994; 12: 162-168.
15. Foster K, Crossey PA, Cairns P et al. Molecular genetic investigation of sporadic renal cell carcinoma: Analysis of allele loss on chromosomes 3p, 5q, 11p, 17 and 22. Br. J. Cancer 1994; 69: 230-234.
16. Willman CL, Sever CE, Pallavicini MG et al. Deletion of IRF-1, mapping to chromosome 5q31.1, in human leukemia and preleukemic myelodysplasia. Science 1993; 259: 968-971.
17. Ogasawara S, Tamura G, Maesawa C et al. Common deleted region on the long arm of chromosome 5 in esophageal carcinoma. Gastroenterology 1996; 110: 52-57.
18. Tamura G, Ogasawara S, Nishizuka S et al. Two distinct regions of deletion on the long arm of chromosome 5 in differentiated adenocarcinomas of the stomach. Cancer Res. 1996; 56: 612-615.
19. Shuin T, Kondo K, Torigoe S et al. Frequent somatic mutations and loss of heterozygosity of the von Hippel-Lindau tumor suppressor gene in primary human renal cell carcinomas. Cancer Res. 1994; 54: 2852-2855.
20. Zbar B, Brauch H, Talmadge C, Linehan M. Loss of alleles of loci on the short arm of chromosome 3 in renal cell carcinoma. Nature 1987; 327: 721-727.
21. van den Berg E, van der Hout AH, Oosterhuis JW et al. Cytogenetic analysis of epithelial renal-cell tumors: Relationship with a new histopathological classification. Int. J. Cancer 1993; 55: 223-227.
22. Soussi T, Legros Y, Lubin R, Ory K, Schlichtholz B. Multifactorial analysis of p53 alteration in human cancer: A review. Int. J. Cancer 1994; 57: 1-9.
23. Uchida T, Wada C, Shitara T, Egawa S, Mashimo S, Koshiba K. Infrequent involvement of p53 mutations and loss of heterozygosity of 17p in the tumorigenesis of renal cell carcinoma. J. Urol. 1993; 150: 1298-1301.
24. Oka K, Ishikawa J, Bruner JM, Takahashi R, Saya H. Detection of loss of heterozygosity in the p53 gene in renal cell carcinoma and bladder cancer using the polymerase chain reaction. Mol. Carcinog. 1991; 4: 10-13.
25. Oda H, Nakatsuru Y, Ishikawa T. Mutations of the p53 gene and p53 protein overexpression are associated with sarcomatoid transformation in renal cell carcinomas. Cancer Res. 1995; 55: 658-662.
26. Mao L, Lee DJ, Tockman MS, Erozan YS, Askin F, Sidransky D. Microsatellite alterations as clonal markers for the detection of human cancer. Proc. Natl Acad. Sci. USA 1994; 91: 9871-9875.
27. Aaltonen LA, Peltomäki P, Leach FS et al. Clues to the pathogenesis of familial colorectal cancer. Science 1993; 260: 812-816.